Glenmark Pharma Stock Drops 6% on Life Sciences Division Sale Plan
Glenmark Pharma witnessed a 6.3 percent drop in its shares during the Friday trading session following its announcement of selling a 75 percent stake in Glenmark Life Science to Nirma…